Navigation Links
Investigation Findings, Corroborated by Empirical Evidence of the,Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine,for Hundreds of Years, Support the Use of Schisandrin B in the,Prevention and Treatment of IHD

nhance the free radical scavenging capacity of the heart, thereby protecting against I-R injury.

The finding, which is corroborated by empirical evidence of the Schisandra berry as cardio-tonic in Traditional Chinese Medicine for hundreds of years, supports the use of Schisandrin B in the prevention and treatment of IHD.

Since the publication of this finding, Dr. Ko has identified an isomer of Schisandrin B, (-) Schisandrin B, a novel discovery, which possesses a more potent pharmacological profile than that of Schisandrin B. Patented use of this newly discovered compound, (-) Schisandrin B, for the prevention and treatment of Ischemic Heart Disease has been applied for with the US Patent and Trademark Office.

For a copy of this research report, please contact the publisher, Molecular and Cellular Biochemistry.

About the Company

MitoPharm Corporation is a biotechnology company in the research & development, marketing and sale of drugs, dietary supplements, and functional beverages. The initial products are based on a newly discovered compound (the "Compound") that is the result of over 15 years of research and development by one of its founding shareholders, the Hong Kong University of Science and Technology ("HKUST"). MitoPharm believes that its products have the potential to play a significant role in addressing the aging concerns of the baby boomers, the heart-health and heart-diseases markets, and the segment of the population that is physically active. www.mitopharm.com

At HKUST, scientific studies have identified biochemical actions of MitoPharm's key Compound, demonstrating that it enhances the mitochondrial glutathione antioxidant status, a crucial factor in maintaining mitochondrial function and cell survival, and also induces the expression of heat shock proteins, another group of important molecules for cell protection. Management's research indicates that these biochemical actions differentiate the Compound f
'"/>




Page: 1 2 3

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
3. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
4. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
5. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
6. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
7. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
10. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
11. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
Post Your Comments:
(Date:5/22/2013)... , May 22, 2013  Milliman, Inc., a ... results of its 2013 Milliman Medical Index (MMI), which ... of four receiving healthcare benefits through an employer-sponsored preferred ... this typical family in 2013 is $22,030. ... the prior year on a percentage basis was the ...
(Date:5/22/2013)... 2013  Modern Medical announced today the nationwide ... November 2012 in a test phase, ODM is ... the rising opioid abuse in the workers, compensation ... to protect employees, physicians and employers by reducing ... to provide pain relief for the injured worker.  ...
(Date:5/22/2013)... -- Pomerantz Grossman Hufford Dahlstrom ... investors of Intuitive Surgical, Inc. ("Intuitive Surgical" or the ... purchased Intuitive Surgical common stock between October 19, 2011 ... are advised to contact Robert S. Willoughby ... 237. The investigation concerns whether Intuitive Surgical ...
Breaking Medicine Technology:Annual Healthcare Cost for a Typical American Family is $22,030 According to 2013 Milliman Medical Index 2Modern Medical Introduces Opioid Abuse Solution to the Workers' Compensation Industry 2SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Surgical, Inc. - ISRG 2
... N.J., Sept. 23 NeoStem, Inc. (NYSE Amex: ... in the U.S. and China and Progenitor Cell Therapy, ... the cell therapy industry from licensed, state-of-the art cell ... jointly announced the signing of a  definitive merger agreement ...
... which represents the interests of the worldwide mobile communications ... Awards programme. New categories have been added to recognise ... evolving mobile ecosystem. Specifically, the GSMA will shine a ... – space for the first time. "Health ...
Cached Medicine Technology:NeoStem and Progenitor Cell Therapy Announce Entry Into Merger Agreement 2NeoStem and Progenitor Cell Therapy Announce Entry Into Merger Agreement 3NeoStem and Progenitor Cell Therapy Announce Entry Into Merger Agreement 4GSMA's Global Mobile Awards To Recognise Mobile Innovation in the mHealth Sector 2
(Date:5/22/2013)... Los Angeles, CA (PRWEB) May 22, 2013 ... therapy4parents.com , hosted by Patricia O’Laughlin Psychotherapy in ... now seeing people of all ages as progression ... “Including children of all ages into parenting therapy ... Patricia O’Laughlin emphasizes. Patricia O’Laughlin Psychotherapy now specializes ...
(Date:5/22/2013)... IA (PRWEB) May 22, 2013 Diversity ... piece Handicap This! The performance promotes awareness that ... dreams. The Handicap This! performance will be held Friday, ... High School auditorium. Tickets for Handicap This! can ... This! helps audiences measure the level to which their ...
(Date:5/22/2013)... May 22, 2013 Today, Zane Benefits, ... Health Insurance Exchange . Zane Benefits, which provides comprehensive ... is the leader in defined contribution plans ... Zane Benefits’ website, beginning in 2014 as part of ... individuals and small businesses will become available through new ...
(Date:5/22/2013)... Over the next two decades, the cost of treating ... than double, topping more than $180 billion a year, ... the increase: an aging population. The report, from the ... was published May 22 in the journal Stroke ... system," Dr. Bruce Ovbiagele, chairman of the department of ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Award Presented ... Read the press release here: http://bit.ly/13DkFfk , ... was named “Information Management Product/Service of the Year” at ... March at The Colony Hotel in Palm Beach, Florida. ... virtual data room (VDR) solution that optimizes the ...
Breaking Medicine News(10 mins):Health News:Patricia O’Laughlin Psychotherapy of Los Angeles Now Seeing Adults, Teens and Young Children 2Health News:Handicap This! Comes to Marion, Iowa 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 3Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 2Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 3Health News:Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year” 2Health News:Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year” 3
... change that has come to Washington is now needed ... leader in prevention.(Logo: http://www.newscom.com/cgi-bin/prnh/20080506/NETU129LOGO )"As the ... capital, the time is ripe to bring a fresh ... Christopher Fey, Chairman and CEO of U.S. Preventive Medicine. ...
... Inc.,(NYSE: HSP ), a leading global specialty pharmaceutical ... conference call to discuss its,fourth-quarter and full-year 2008 results and ... Central time. , The company will ... the U.S. stock market open and the conference,call. , ...
... As unemployment continues to,rise in the United States, Americans are ... what would happen if they were struck with a,serious medical ... pay for,the care? But the widely known benefit of hospice ... available to all eligible,Americans - whether they are employed or ...
... Americans who use illegal diet pills from South America ... both their health and their jobs. Physicians need to ... effects of these drugs to allow them to identify ... findings1, by Dr Pieter Cohen from the Department of ...
... 26, 2009) There is hope that the drug rasagiline ... does -- slow the progression of a devastating degenerative brain ... and function. , Now a new study looking at ... indicates that people who began the drug earlier continued to ...
... offers retailing veterans a 25% discount on the initial ... strongest and best franchise organizationPITTSBURGH, Jan. 26 Despite ... which has cost thousands of experienced retail employees their ... $21 billion industry and continues to grow at a ...
Cached Medicine News:Health News:U.S. Preventive Medicine Recommends Changing CDC Name to Centers for Disease Prevention and Control 2Health News:Hospice Care Remains a Misunderstood and Underutilized Benefit, According to In-House Hospice 2Health News:Hospice Care Remains a Misunderstood and Underutilized Benefit, According to In-House Hospice 3Health News:Caution: Lose more than weight with imported diet pills 2Health News:Patients starting Parkinson's drug rasagiline earlier do better 2Health News:Lost Your Job in Retail? Why Not Operate Your Own Business in 2009! Invest in You. Become an Entrepreneur! 2Health News:Lost Your Job in Retail? Why Not Operate Your Own Business in 2009! Invest in You. Become an Entrepreneur! 3
ELVeS is a new minimally-invasive laser treatment for patients with superficial vein reflux of the greater saphenous vein. The ELVeS laser treatment offers your patients an effective out-patient alt...
... EVLT, the #1 physician choice in laser ... to remedying superficial vein reflux. EVLT is ... surgical vein stripping that effectively and safely ... fiber to occlude the vein. The procedure ...
...
Inquire...
Medicine Products: